Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-464 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-464, RRID:AB_10002158
- Product name
- Rabbit Polyclonal Chk1 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 ul
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C. Do not freeze.
Submitted references Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma.
Two subunits of human ORC are dispensable for DNA replication and proliferation.
Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy.
Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924.
Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork progression after DNA damage.
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
The effect of the intra-S-phase checkpoint on origins of replication in human cells.
Involvement of the ATR- and ATM-dependent checkpoint responses in cell cycle arrest evoked by pierisin-1.
Bai X, Wang J, Huo L, Xie Y, Xie W, Xu G, Wang M
Translational oncology 2018 Feb;11(1):140-146
Translational oncology 2018 Feb;11(1):140-146
Two subunits of human ORC are dispensable for DNA replication and proliferation.
Shibata E, Kiran M, Shibata Y, Singh S, Kiran S, Dutta A
eLife 2016 Dec 1;5
eLife 2016 Dec 1;5
Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy.
Yun H, Shi R, Yang Q, Zhang X, Wang Y, Zhou X, Mu K
Scientific reports 2014 Dec 18;4:7548
Scientific reports 2014 Dec 18;4:7548
Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924.
Jazaeri AA, Shibata E, Park J, Bryant JL, Conaway MR, Modesitt SC, Smith PG, Milhollen MA, Berger AJ, Dutta A
Molecular cancer therapeutics 2013 Oct;12(10):1958-67
Molecular cancer therapeutics 2013 Oct;12(10):1958-67
Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork progression after DNA damage.
Terai K, Shibata E, Abbas T, Dutta A
The Journal of biological chemistry 2013 Oct 18;288(42):30509-14
The Journal of biological chemistry 2013 Oct 18;288(42):30509-14
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
Hong J, Hu K, Yuan Y, Sang Y, Bu Q, Chen G, Yang L, Li B, Huang P, Chen D, Liang Y, Zhang R, Pan J, Zeng YX, Kang T
The Journal of clinical investigation 2012 Jun;122(6):2165-75
The Journal of clinical investigation 2012 Jun;122(6):2165-75
The effect of the intra-S-phase checkpoint on origins of replication in human cells.
Karnani N, Dutta A
Genes & development 2011 Mar 15;25(6):621-33
Genes & development 2011 Mar 15;25(6):621-33
Involvement of the ATR- and ATM-dependent checkpoint responses in cell cycle arrest evoked by pierisin-1.
Shiotani B, Kobayashi M, Watanabe M, Yamamoto K, Sugimura T, Wakabayashi K
Molecular cancer research : MCR 2006 Feb;4(2):125-33
Molecular cancer research : MCR 2006 Feb;4(2):125-33
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: Chk1 Antibody [NB100-464] - Detection of Human Chk1 by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa, 293T, Jurkat, and mouse TMCK cells. Antibodies: Affinity purified rabbit anti-Chk1 antibody NB100-464 used for WB at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunoprecipitation: Chk1 Antibody [NB100-464] - Detection of human Chk1 by western blot of immunoprecipitates. Samples: Whole cell lysate (1 mg for IP; 20% of IP loaded) from HeLa cells. Antibodies: Affinity purified rabbit anti-Chk1 antibody NB100-464 (lot 2) used for IP at 6 ug/mg lysate. Chk1 was also immunoprecipitated by a previous lot (lot 1) of this antibody. For blotting immunoprecipitated Chk1, NB100-464 (lot 2) was used at 1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Chk1 Antibody [NB100-464] - Section of human breast carcinoma. Antibody: Affinity purified rabbit anti-CHK1 used at a dilution of 1:1,000 (1ug/ml). Detection: DAB